help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tonko-Geymayer, S.
Right arrow Articles by Doppler, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tonko-Geymayer, S.
Right arrow Articles by Doppler, W.
Molecular Endocrinology 16 (7): 1680-1695
Copyright © 2002 by The Endocrine Society

Regulation and Function of the Cytokine-Inducible SH-2 Domain Proteins, CIS and SOCS3, in Mammary Epithelial Cells

Sibylle Tonko-Geymayer, Olivier Goupille, Martin Tonko, Claudia Soratroi, Akihiko Yoshimura, Charles Streuli, Andrew Ziemiecki, Reinhard Kofler and Wolfgang Doppler

Institut für Medizinische Chemie und Biochemie (S.T.-G., O.G., C.S., W.D.) and Institut für Pathophysiologie (M.T., R.K.), Abteilung Molekulare Pathophysiologie, Universität Innsbruck, and Tyrolean Cancer Research Institute, A-6020 Innsbruck, Austria; Molecular and Cellar Immunology (A.Y.), Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka, 812-8582, Japan; Department of Cell and Structural Biology (C.S.), University of Manchester, Manchester M13 9PT, United Kingdom; and Department of Clinical Research (A.Z.), University of Berne, CH-3004 Berne, Switzerland

Address all correspondence and requests for reprints to: Wolfgang Doppler, Institut für Medizinische Chemie und Biochemie, Universität Innsbruck, Fritz Pregl-Strasse 3, A-6020 Innsbruck, Austria. E-mail: Wolfgang.Doppler{at}uibk.ac.at.

The cytokine-inducible src homology 2 (SH-2) proteins, CIS (cytokine inducible SH-2 domain protein) and SOCS3 (suppressor of cytokine signaling 3), are implicated in the negative regulation of prolactin (PRL) receptor-mediated activation of signal transducer and activator of transcription 5 (STAT5). We have studied the expression and function of CIS and SOCS3 proteins in the mouse mammary gland and in HC11 mammary epithelial cells. CIS and SOCS3 were differentially regulated: high expression levels of CIS mRNA were measured during the second half of pregnancy, whereas SOCS3 expression was high during the first 12 d post conceptum. SOCS3 levels increased, whereas CIS levels decreased, in the initial phase of involution. At the beginning of the lactation period both CIS and SOCS3 were high. PRL and epidermal growth factor (EGF) were able to induce CIS and SOCS3, whereas glucocorticoids inhibited their expression in mammary epithelial cells. The effect of EGF was much stronger on SOCS3 than on CIS. Ectopic expression of both SOCS3 and CIS inhibited STAT5 activation. Our data indicate that in the mammary gland CIS and SOCS3 are involved in regulating STAT5 signaling at three different instances: 1) SOCS3 serves as a mediator of the inhibitory EGF effect on PRL-induced STAT5 activation; 2) CIS and SOCS3 play a role as negative feedback inhibitors of PRL action; 3) Inhibition of CIS and SOCS3 expression by glucocorticoids contributes to the positive effect of glucocorticoids on PRL-induced STAT5 activation.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
H. Neuwirt, M. Puhr, I. T Cavarretta, M. Mitterberger, A. Hobisch, and Z. Culig
Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion
Endocr. Relat. Cancer, December 1, 2007; 14(4): 1007 - 1019.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. L. Barclay, S. T. Anderson, M. J. Waters, and J. D. Curlewis
Characterization of the SOCS3 Promoter Response to Prostaglandin E2 in T47D Cells
Mol. Endocrinol., October 1, 2007; 21(10): 2516 - 2528.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. M. Arendt, T. A. Rose-Hellekant, E. P. Sandgren, and L. A. Schuler
Prolactin Potentiates Transforming Growth Factor {alpha} Induction of Mammary Neoplasia in Transgenic Mice
Am. J. Pathol., April 1, 2006; 168(4): 1365 - 1374.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. V. Clevenger
Roles and Regulation of Stat Family Transcription Factors in Human Breast Cancer
Am. J. Pathol., November 1, 2004; 165(5): 1449 - 1460.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kimura, I. Kinjyo, Y. Matsumura, H. Mori, R. Mashima, M. Harada, K. R. Chien, H. Yasukawa, and A. Yoshimura
SOCS3 Is a Physiological Negative Regulator for Granulopoiesis and Granulocyte Colony-stimulating Factor Receptor Signaling
J. Biol. Chem., February 20, 2004; 279(8): 6905 - 6910.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Endo, A. Sasaki, M. Minoguchi, A. Joo, and A. Yoshimura
CIS1 Interacts with the Y532 of the Prolactin Receptor and Suppresses Prolactin-Dependent STAT5 Activation
J. Biochem., January 1, 2003; 133(1): 109 - 113.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society